Author: Jane Russell

Positive early findings from ProQR trial of USH2A therapy

April 3, 2020

Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a …

Useful links during Covid-19 pandemic

March 31, 2020

The following list of useful links have been compiled by the team at Retina UK to provide information and support for our community. The list is updated regularly. However, in …

Retina UK COVID-19 response

March 17, 2020

During these uncertain times, the health and wellbeing of our community is our upmost priority at Retina UK. In light of Government guidance we have made the difficult decision to …

First clinical trial participant receives CRISPR-based therapy

March 4, 2020

An American living with Leber congenital amaurosis 10 (LCA10) has become the first clinical trial participant in the world to receive a CRISPR gene editing treatment in vivo (inside the …

Popular historic drama features retinitis pigmentosa

March 2, 2020

We were delighted to support the BBC1 drama Call the Midwife production team with their historical research for an episode featuring a character living with retinitis pigmentosa (RP). Professor John …

First patient receives ground-breaking treatment

In January 23-year-old Jake Ternent became the first person with an inherited sight loss condition to be treated in the UK with Luxturna (voretigene neparvovec) for Leber congenital amaurosis (LCA). …

Gene therapy shows promise in tackling X-linked RP

February 28, 2020

Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients. The treatment targets retinal degeneration …

Genetic testing: an essential topic for discussion with the IRD communtiy

February 13, 2020

As Luxturna reaches the clinic and other gene-specific therapies for inherited retinal disease get closer to the end of the development pipeline, it is becoming ever more important that affected …

Latest update from ReNeuron stem cell trial

November 15, 2019

ReNeuron has announced an encouraging update on the progress of its Phase 1/2 trial of a stem cell-based therapy for retinitis pigmentosa, describing the most recent results as a “clear …

Recognition for Retina UK volunteer at Helplines Partnerships Awards

November 12, 2019

Congratulations and a huge well done to Elizabeth Baio who was awarded 3rd place in the Volunteer of the Year awards at the Helplines Partnership Conference on Wednesday 6 November. …

Informative and positive first Professionals’ Conference from Retina UK

October 2, 2019

Overwhelming positive feedback has been received from the 180 delegates who joined us for our first Professionals’ Conference. The education, health and social-care professionals who attended the event on Friday …

Press release: Retina UK publishes unique insight into the experiences of people with inherited retinal conditions

September 13, 2019

Evidence of the real-life experiences, challenges and expectations of almost 1,000 people affected by inherited sight loss conditions have been published by national sight loss charity Retina UK. The charity …